Shinkichi Takamori Takashi Seto Masafumi Yamaguchi Fumihiko Kinoshita Takatoshi Fujishita Kensaku Ito Ryo Toyozawa Fumihiro Shoji Tatsuro Okamoto
10.3389/fonc.2022.965741
Front Oncol
2022 Oct 13;12:965741.
metex14del lung adenocarcinoma osimertinib resistance tepotinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/36313664/
Case Reports
PMC9608750
36313664
Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation
2022